While pursuing another pro-resolution pathway, the FPR2/ALX pathway additionally targets neutrophils themselves via Akt and ERK1/2 signaling in sickle cell disease, limiting the pro-NETosis phenotype of neutrophils and aiding in resolution of thrombo-inflammation [279]. This evidence concerns the gene FPR2 and sickle cell disease.